MedPath

An RCT for the evaluation of the effects of Real Time Medication Monitoring (RTMM) on improving medication adherence in diabetes type 2 patients in the Netherlands.

Recruiting
Conditions
Diabetes Mellitus type 2, medication adherence
Registration Number
NL-OMON19988
Lead Sponsor
IVEL Netherlands Institute for Health Services Research, Mediq Apotheken, Evalan BV
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
210
Inclusion Criteria

1. Using oral antidiabetic medication for at least one year;

2. Having an adherence level of <80% according to pharmacy refill data from the year preceding the intervention;

Exclusion Criteria

1. Age <18 years or >65 years;

2. Not understanding/speaking Dutch.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Adherence to oral antidiabetic medication.
Secondary Outcome Measures
NameTimeMethod
1. Changes in patients' beliefs about medicines (BMQ-Specific);<br /><br>2. Illness perceptions (Brief IPQ);<br /><br>3. Levels of bloodglucose (HbA1c).
© Copyright 2025. All Rights Reserved by MedPath